Skip to main content
. 2022 Dec 16;12:1073036. doi: 10.3389/fonc.2022.1073036

Table 1.

The details surrounding the patient’s treatment: HGG, high-grade glioma; STR, subtotal resection; GTR, gross-total resection.

Tumor localization Number and extent of surgical treatments for HGG (time relapse) Histological examination Infectious complication/number of surgical treatments for infectious complications (etiology/antibiotic resistance) ATB treatment (duration) Outcome
Case 1 Left parietal lobe 1. HGG resection (STR)
2. HGG resection after 5 months (GTR)
Glioblastoma WHO G IV, IDH-wildtype, MGMT promoter hypermethylation Osteomyelitis/4
Staphylococcus aureus/resistance to clindamycin and erythromycin
Biseptol (680 days)
Cefuroxime (60 days)
Linezolid (21 days)
Ospamo (23 days)
disease-free survival of 61 months
Case 2 Left frontal lobe 1. HGG resection (GTR)
2. HGG resection after 6 years (GTR)
Anaplastic astrocytoma, WHO GIII, IDH-mutant Osteomyelitis/2
Staphylococcus aureus/not resistant
Pseudomonas aeruginosa/resistant to piperacillin+tazobactam and ciprofloxacin
Klebsiella pneumoniae/resistant to chloramphenicol and Biseptol)
Biseptol (60 days)
Ceftazidime (14 days)
disease-free survival of 152 months